ExeVir Bio fetches Series A
ExeVir Bio, a Belgian life sciences institute, has raised 23 million euros in Series A funding.
ExeVir Bio, a Belgian life sciences institute, has raised 23 million euros in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination
